<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Oral Patol Oral Cir Bucal</journal-id><journal-id journal-id-type="iso-abbrev">Med Oral Patol Oral Cir Bucal</journal-id><journal-id journal-id-type="publisher-id">Medicina Oral S.L.</journal-id><journal-title-group><journal-title>Medicina Oral, Patolog&#x000ed;a Oral y Cirug&#x000ed;a Bucal</journal-title></journal-title-group><issn pub-type="ppub">1698-4447</issn><issn pub-type="epub">1698-6946</issn><publisher><publisher-name>Medicina Oral S.L.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39954279</article-id><article-id pub-id-type="pmc">PMC11972652</article-id>
<article-id pub-id-type="publisher-id">26788</article-id><article-id pub-id-type="doi">10.4317/medoral.26788</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject><subj-group><subject>Oral Surgery</subject></subj-group></subj-group></article-categories><title-group><article-title>Certainty of evidence on the effects of cryotherapy, surgical wound closure, and chlorhexidine on clinical and patient-centered outcomes after third molar surgery: evidence mapping of systematic reviews and meta-analyses</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>do Nascimento-J&#x000fa;nior</surname><given-names>Edmundo Marques</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Costa</surname><given-names>F&#x000e1;bio Wildson Gurgel</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Martins-Filho</surname><given-names>Paulo Ricardo</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A4" ref-type="aff">4</xref></contrib></contrib-group><aff id="A1"><label>1</label>Graduate Program in Dentistry, Federal University of Sergipe, Aracaju, SE, Brazil</aff><aff id="A2"><label>2</label>Investigative Pathology Laboratory, Federal University of Sergipe, Aracaju, SE, Brazil</aff><aff id="A3"><label>3</label>Division of Oral and Maxillofacial Surgery, Graduate Program in Dentistry, Federal University of Cear&#x000e1;, Fortaleza, CE, Brazil</aff><aff id="A4"><label>4</label>Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, SE, Brazil</aff><author-notes><corresp> Universidade Federal de Sergipe
Hospital Universit&#x000e1;rio, Laborat&#x000f3;rio de Patologia Investigativa
Rua Cl&#x000e1;udio Batista, s/n. Bairro Sanat&#x000f3;rio
CEP: 49060-100, Aracaju, Sergipe, Brasil
, E-mail: <email>prmartinsfh@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>15</day><month>2</month><year>2025</year></pub-date><volume>30</volume><issue>2</issue><fpage>e199</fpage><lpage>e210</lpage><history><date date-type="accepted"><day>17</day><month>1</month><year>2025</year></date><date date-type="received"><day>1</day><month>7</month><year>2024</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2025 Medicina Oral S.L.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/2.5/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background </title><p> Removal of third molars often leads to complications such as pain, swelling, and trismus, impacting patient quality of life. Various strategies including cryotherapy, different suture techniques, and chlorhexidine are employed to mitigate these effects. However, the effectiveness of these interventions is still debated, as clinical trials present inconsistent and contrasting results. This study aims to assess the certainty of evidence from systematic reviews and meta-analyses regarding the effects of these interventions on clinical outcomes and patient quality of life following third molar surgery.</p></sec><sec><title>Material and Methods </title><p> This evidence mapping followed the Global Evidence Mapping Initiative and PRISMA guidelines, utilizing databases such as PubMed, Embase, Cochrane, Web of Science, and Google Scholar until February 2024. Methodological quality was assessed via AMSTAR-2 and the effects of these interventions on outcomes of interest were classified as "beneficial", "probably beneficial", "harmful", "no effect", or "inconclusive". Findings were mapped using the PyMeta platform.</p></sec><sec><title>Results </title><p> Thirteen studies were reviewed. All systematic reviews evaluated the effects of these interventions on clinical outcomes following third molar surgery, but none assessed the impact on patient quality of life. Cryotherapy was classified as probably beneficial for reducing pain and swelling within the first 72 hours post-surgery. Secondary surgical wound closure was effective in reducing pain, swelling, and trismus during the first postoperative week, but it did not mitigate the risk of bleeding, infection, or alveolitis. Chlorhexidine, especially when used as a mouthwash, is effective in preventing postoperative alveolitis. However, most reviews (76.9%) were rated as "critically low" methodological quality.</p></sec><sec><title>Conclusions </title><p> Although the potential benefits of cryotherapy, secondary surgical wound closure, and chlorhexidine on clinical outcomes, this study revealed a predominantly low quality of evidence from systematic reviews and meta-analyses. Moreover, further research should expand investigations into the patient-centered outcomes to better guide clinical practice.</p><p><bold> Key words:</bold>Third molar, oral surgery, postoperative complications, pain, edema, cryotherapy, suture techniques, chlorhexidine, evidence-based dentistry.</p></sec></abstract></article-meta></front><body><sec><title>Introduction</title><p>The extraction of third molars is a common dental procedure, often indicated due to complications such as impaction or misalignment (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>). Despite its routine nature, this procedure can lead to several postoperative complications, including pain, swelling, trismus, alveolitis, and infections (<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>), significantly affecting patient's daily activities and overall well-being (<xref rid="B5" ref-type="bibr">5</xref>). To mitigate these adverse outcomes, various preventive and therapeutic strategies are employed in clinical practice, such as cryotherapy (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B6" ref-type="bibr">6</xref>), diverse wound closure techniques (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>), and the use of antiseptics like chlorhexidine (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>).</p><p>However, the efficacy of these interventions remains a topic of debate in the literature, with some clinical trials reporting modest or inconclusive results, while others demonstrate significant improvements in postoperative outcomes (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B11" ref-type="bibr">11</xref>). This inconsistency underscores the need for comprehensive and systematic evaluations of the existing evidence. Systematic reviews and meta-analyses address this need by synthesizing data from multiple studies and critically assessing the certainty of available evidence, thereby providing more reliable conclusions regarding the effectiveness of these interventions.</p><p>This study aims to assess the certainty of evidence from systematic reviews and meta-analyses regarding the effects of cryotherapy, surgical wound closure, and chlorhexidine on clinical outcomes and quality of life in patients undergoing third molar surgery. Through this evidence mapping, we aim to identify and address existing gaps in the literature, thereby informing future research and optimizing outcomes following third molar extractions.</p></sec><sec><title>Material and Methods</title><p>We conducted an evidence mapping according to the Global Evidence Mapping Initiative methodology (<xref rid="B12" ref-type="bibr">12</xref>) and adhered to the PRISMA Extension for Scoping Reviews (<xref rid="B13" ref-type="bibr">13</xref>) (Supplement 1). Our approach also included an assessment of the methodological quality of the reviews included (<xref rid="B14" ref-type="bibr">14</xref>). The protocol for our study was registered a priori on the Open Science Framework platform (https://doi.org/10.17605/OSF.IO/DAST9).</p><p>- Research question</p><p>This evidence mapping was conducted to address the following research question: &#x0201c;What is the certainty of the available evidence regarding the effects of cryotherapy, surgical wound closure, and chlorhexidine on clinical outcomes and quality of life after third molar surgery?&#x0201d;</p><p>- Eligibility criteria</p><p>We included systematic reviews regardless of publication year or language. These reviews must focus on evaluating the effectiveness of cryotherapy, surgical wound closure techniques, and the use of chlorhexidine in managing postoperative complications following third molar extractions. Each systematic review had to report at least one of the following outcomes: pain, swelling, trismus, bleeding, surgical wound infection, or alveolitis. Additionally, we sought to identify reviews that assessed the impact of these complications on the quality of life of patients undergoing these procedures. In cases of updated systematic reviews, both studies were retained, as many reviews improve their methodology and address limitations over time. Systematic reviews without meta-analysis, overview-type studies, and network meta-analyses were excluded.</p><p>- Search strategy</p><p>We conducted a systematic search in four databases (PubMed, Embase, Cochrane, and Web of Science) in September 2023, with an update in February 2024, to identify systematic reviews and meta-analyses relevant to our study. Additionally, we evaluated the top 100 search results on Google Scholar. Our search strategy used a comprehensive approach, incorporating Medical Subject Headings (MeSH) and Entry Terms (EMTREE), along with specific keywords related to our topics of interest, including variations such as: "Third molar", "Third molars", "Wisdom tooth", "Wisdom teeth", "Cryotherapy", "Cold therapy", "Ice", "Suture", "Sutures", "Suture technique", "Suture techniques", "Closure technique", "Closure techniques", "Closure ways", "Primary closure", "Secondary closure", "Wound closure", "Wound healing", "Surgical wound", and "Chlorhexidine".</p><p>To ensure thorough coverage, we tailored the search strategy for each database. Additionally, we performed a manual search through the reference lists of the included systematic reviews to identify any relevant studies might have been overlooked during the electronic database searches. We conducted separate searches for each intervention of interest&#x02014;cryotherapy, surgical wound closure techniques, and chlorhexidine&#x02014;to guarantee thorough and pertinent results for each intervention. Detailed search strategies for each database are outlined in the Supplement 2, providing transparency and facilitating the reproducibility of our search methodology for future research.</p><p>- Selection of systematic reviews</p><p>We managed all retrieved titles and abstracts using the Ryyan platform (available at https://www.rayyan.ai/). After removing duplicates, two reviewers (EMNJ and PRMF) independently screened all titles and abstracts for potentially relevant studies. Subsequently, potentially eligible articles were set aside for full-text reading and decision-making. Discrepancies were resolved by consensus or consultation with a third reviewer (JWGC). Detailed explanations were provided for the exclusion of any study after full-text review.</p><p>- Methodological quality assessment of systematic reviews</p><p>We evaluated the methodological quality of each included systematic review using the AMSTAR-2 tool (<xref rid="B15" ref-type="bibr">15</xref>). This validated instrument consists of 16 items specifically designed to critically assess the quality of systematic reviews. The overall rating is derived from identified weaknesses in key domains, notably items 2, 4, 7, 9, 11, 13, and 15. Confidence in the review outcomes is classified into four levels: "High", indicating no or only one non-critical weakness; "Moderate", indicating the presence of more than one non-critical weakness; "Low", applicable when there is one critical flaw, with or without additional non-critical weaknesses; and "Critically Low", applicable when multiple critical flaws are present, with or without non-critical weaknesses.</p><p>Two researchers (EMNJ and PRMF) independently conducted the methodological quality assessments using the tool&#x02019;s online checklist (https://amstar.ca/Amstar_Checklist.php). Following the discussion of individual findings, we compiled a Table detailing the quality of evidence rating for each review. If a review was authored by one of the researchers responsible for this phase, a third reviewer (EMNJ and PRMF) was appointed for the assessment.</p><p>- Data extraction</p><p>Data extraction was also performed by two researchers (EMNJ and PRMF), independently, using a pre-formatted Excel spreadsheet. Discrepancies were resolved by consensus or consultation with a third reviewer (EMNJ and PRMF). The following information was extracted from the selected systematic reviews:</p><p>1. Authors, country, and year of publication.</p><p>2. Number of clinical trials included.</p><p>3. Population.</p><p>4. Interventions: cryotherapy, surgical wound closure, or chlorhexidine.</p><p>5. Comparisons.</p><p>a. For cryotherapy: non-use of ice.</p><p>b. Surgical wound closure: primary closure with suture versus secondary closure.</p><p>c. For chlorhexidine: placebo, any other substance used for the same purpose, or no treatment.</p><p>6. Outcomes of interest:</p><p>a. For cryotherapy: pain, swelling, trismus, and quality of life.</p><p>b. For wound closure: pain, swelling, trismus, bleeding, surgical wound infection, alveolitis, and quality of life.</p><p>c. For chlorhexidine: surgical wound infection, alveolitis, and quality of life.</p><p>7. Tool used for risk of bias assessment.</p><p>8. Assessment of evidence certainty through the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) (<xref rid="B16" ref-type="bibr">16</xref>).</p><p>- Effects of interventions on outcomes of interest</p><p>The impacts of the interventions on the outcomes of interest were evaluated primarily through findings from meta-analyses, with a particular focus on forest plots. This analysis extended beyond mere summary measures; it also examined the direction and confidence intervals of the effects observed in individual studies included in each meta-analysis. Such a comprehensive approach enables a detailed interpretation of results, enhancing our understanding of the effect magnitude of the assessed interventions.</p><p>The effects of cryotherapy, surgical wound closure, and chlorhexidine in the postoperative period after third molar removal were classified as: 1) "Beneficial": when the summary measure demonstrated a significant reduction in postoperative complications, supported by confidence intervals from individual studies that mostly did not cross the null line, indicating a clear improvement in the outcomes of interest; 2) "Probably beneficial": when the summary measure showed a reduction in postoperative complications, although with confidence intervals from individual studies approaching the null line. Such results indicated a possible advantage of the interventions, requiring, however, more evidence for a definitive conclusion; 3) "Harmful": interventions were considered harmful when the summarized results pointed to a significant increase in postoperative complications compared to the comparison group; 4) "No effect": this classification was applied when the summary measure did not demonstrate a significant difference in postoperative complications between compared groups; 5) "Inconclusive": assigned to interventions whose results did not allow for a clear interpretation due to limitations such as wide confidence intervals, insufficient studies, or significant variability in the results of the studies. This category reflects the need for additional research to clarify the effect of the interventions.</p><p>- Presentation of evidence mappings</p><p>We displayed the evidence mappings using bubble charts, where each bubble corresponds to a systematic review. These charts provide information in three dimensions: 1) the classification of the effects of the interventions represented on the X-axis; 2) the AMSTAR-2 assessment on the Y-axis; and 3) the author, year, and size of the population included in each systematic review above each bubble, with the size of the bubble proportional to the size of the population. Additionally, we also presented Tables describing the characteristics of the studies shown in the bubble charts, including information about authors, follow-up period, measure, and effect. The Figures were generated using the PyMeta platform (https://www.pymeta.com/evdmap/).</p></sec><sec><title>Results</title><p>- Selected studies</p><p>The database search resulted in 520 records, including 114 for cryotherapy, 242 for surgical wound closure methods, and 164 for chlorhexidine. Following the initial screening based on titles and abstracts, 17 studies were selected for full-text review (three related to cryotherapy, six to wound closure, and eight to chlorhexidine. Out of these, 13 systematic reviews (two on cryotherapy, five on wound closure, and six on chlorhexidine) (<xref rid="B17" ref-type="bibr">17</xref>-<xref rid="B29" ref-type="bibr">29</xref>) met the eligibility criteria. The search and selection process are thoroughly detailed in Fig. <xref rid="F1" ref-type="fig">1</xref> list of excluded studies, with the reasons for their exclusion, is provided in the Supplement 3.</p><p>- Characteristics of included systematic reviews</p><p>All included systematic reviews conducted meta-analyses for at least one of the evaluated outcomes and were published in English from 2005 to 2024. Two reviews (<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B18" ref-type="bibr">18</xref>) specifically focused on the effects of cryotherapy, four (<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B21" ref-type="bibr">21</xref>-<xref rid="B23" ref-type="bibr">23</xref>) exclusively on surgical wound closure methods, and five (<xref rid="B24" ref-type="bibr">24</xref>-<xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B29" ref-type="bibr">29</xref>) on the use of chlorhexidine. One review (<xref rid="B28" ref-type="bibr">28</xref>) examined various interventions for alveolitis, though data pertaining only to chlorhexidine were extracted for this study. Another review (<xref rid="B20" ref-type="bibr">20</xref>) investigated multiple interventions and their impacts on various outcomes; however, we extracted data related to wound closure.</p><p>All studies investigating cryotherapy evaluated edema and trismus, but only one (<xref rid="B18" ref-type="bibr">18</xref>) assessed pain. In the case of surgical wound closure, all studies assessed pain, edema, and trismus; four studies additionally explored bleeding (<xref rid="B19" ref-type="bibr">19</xref>-<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B23" ref-type="bibr">23</xref>), and three surgical wound infection and alveolitis (<xref rid="B19" ref-type="bibr">19</xref>-<xref rid="B21" ref-type="bibr">21</xref>). As for the studies on chlorhexidine, all systematically reviewed alveolitis. None of the studies across these interventions reported data on quality of life.</p><p>The number of clinical trials included in each review varied from 4 to 40. Twelve reviews used a tool to assess the quality of primary studies, with eleven using the Cochrane Collaboration tool (<xref rid="B17" ref-type="bibr">17</xref>-<xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B26" ref-type="bibr">26</xref>-<xref rid="B29" ref-type="bibr">29</xref>) and one using the Macaskill, Gleser-Olkin, and Rosenthal method (<xref rid="B25" ref-type="bibr">25</xref>) Only six reviews applied the GRADE methodology (<xref rid="B18" ref-type="bibr">18</xref>-<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B28" ref-type="bibr">28</xref>) to assess the quality of evidence from individual studies. <xref rid="T1" ref-type="table">Table 1</xref> presents the general characteristics of the included systematic reviews.</p><p>
<fig position="float" id="F1"><label>Figure 1</label><caption><p>PRISMA flowchart detailing the selection process.</p></caption><graphic xlink:href="medoral-30-e199-g001" position="float"/></fig>
</p><p>- Methodological quality of systematic reviews</p><p>Ten systematic reviews (<xref rid="B17" ref-type="bibr">17</xref>-<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B21" ref-type="bibr">21</xref>-<xref rid="B27" ref-type="bibr">27</xref>) were rated as "critically low", one (<xref rid="B29" ref-type="bibr">29</xref>) as "moderate", and only two (<xref rid="B20" ref-type="bibr">20</xref>,<xref rid="B28" ref-type="bibr">28</xref>) as "high" methodological quality, according to the AMSTAR-2 criteria. Most reviews were downgraded for not referencing a protocol (nine studies; 69.2%) and for not providing a list of excluded studies (eight studies; 61.5%). All information regarding the application of AMSTAR-2 is detailed in Fig. <xref rid="F2" ref-type="fig">2</xref>.</p><p>- Evidence mapping and effects of interventions of interest</p><p>The evidence mapping on cryotherapy, surgical wound closure type, and the use of chlorhexidine in reducing pain, swelling, and trismus, and in preventing bleeding, infection, and alveolitis after third molar removal surgery revealed 66 analyses on the effects of these interventions across various controls and outcomes.</p><p>- Cryotherapy</p><p>Two systematic reviews (<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B18" ref-type="bibr">18</xref>) evaluated the effectiveness of cryotherapy in reducing pain, swelling, and trismus. Cryotherapy was deemed "probably beneficial" for reducing pain on the second and third postoperative days, as well as for diminishing swelling on the second postoperative day. However, the quality of the studies that provided these findings was rated as "critically low" according to AMSTAR-2 criteria. There is no evidence to support the effectiveness of cryotherapy in alleviating pain on the first- and seventh-days post-surgery, reducing swelling from the third postoperative day, or in attenuating trismus at any later stage following the surgical procedure. All information extracted regarding the effects of cryotherapy is detailed in <xref rid="T2" ref-type="table">Table 2</xref> and a bubble chart displaying these results is available in Fig. <xref rid="F3" ref-type="fig">3</xref>.</p><p>
<fig position="float" id="F2"><label>Figure 2</label><caption><p>Assessment of the Methodological Quality of Systematic Reviews (AMSTAR-2) included.</p></caption><graphic xlink:href="medoral-30-e199-g002" position="float"/></fig>
</p><p>
<fig position="float" id="F3"><label>Figure 3</label><caption><p>Evidence mappings on the effects of (A) cryotherapy, (B and C) surgical wound closure, and (D) chlorhexidine on clinical outcomes after third molar surgery.</p></caption><graphic xlink:href="medoral-30-e199-g003" position="float"/></fig>
</p><p>- Surgical wound closure</p><p>Five systematic reviews (<xref rid="B19" ref-type="bibr">19</xref>-<xref rid="B23" ref-type="bibr">23</xref>) evaluated the efficacy of secondary closure, compared to primary closure, in reducing pain, swelling, and trismus, and in preventing bleeding, wound infection, and alveolitis. Generally, secondary closure was considered "beneficial" or "probably beneficial" in reducing pain, swelling, and trismus during the first week of postoperative. However, the evidence quality was considered "high" only for reducing pain on the first postoperative day and swelling after seven days of surgery. For other outcomes and evaluation times, the evidence quality was "critically low". No evidence was found supporting the reduction of bleeding, infection, or alveolitis risk with the secondary closure technique. All information extracted about the effects of secondary surgical wound closure is presented in <xref rid="T3" ref-type="table">Table 3</xref> and bubbles charts with these results can be seen in Fig. <xref rid="F3" ref-type="fig">3</xref>.</p><p>- Chlorhexidine</p><p>Six systematic reviews assessed the efficacy of chlorhexidine as a preventive agent for postoperative alveolitis (<xref rid="B24" ref-type="bibr">24</xref>-<xref rid="B29" ref-type="bibr">29</xref>). The best available evidence characterizes chlorhexidine, especially when used as a mouthwash, as "beneficial" or "probably beneficial" in preventing alveolitis. All information extracted for the effects of chlorhexidine is recorded in <xref rid="T4" ref-type="table">Table 4</xref> and a bubble chart with these results can be seen in Fig. <xref rid="F3" ref-type="fig">3</xref>.</p></sec><sec><title>Discussion</title><p>This study represents one of the initial efforts in oral surgery to employ evidence mapping for third molar removal, assessing the certainty of evidence concerning the effects of cryotherapy, surgical wound closure, and chlorhexidine in alleviating common postoperative complications. While not intended to supplant established clinical protocols or guidelines, our analysis provides a thorough and critical synthesis that highlights both the potential advantages and constraints of these interventions. Recommendations arising from our findings should be interpreted within the specific clinical context of each patient, considering alternative approaches, cost-effectiveness, and other pertinent contextual factors.</p><p>The results of our evidence mapping indicate a limited and variable quality among systematic reviews assessing the discussed interventions and outcomes. From a total of 520 records found across multiple databases, only 17 systematic reviews were identified and selected for full reading. Of these, only 13 met the inclusion criteria. Although most of the included reviews present a limited number of primary studies, all of them were based on clinical trial data, which is considered the highest level of evidence for evaluating the efficacy of therapeutic interventions (<xref rid="B30" ref-type="bibr">30</xref>).</p><p>However, the methodological quality of the reviews analyzed varied significantly, with many categorized as "low" or "critically low". This study underscores the prevalence of methodological shortcomings, including the lack of predefined protocols, insufficient justification for including certain study types, and a lack of publication bias assessment. Such deficiencies can undermine the reliability of the results and, consequently, the credibility of clinical recommendations derived from these reviews. Although not a required step in evidence mapping, it is recommended that all types of reviews incorporate a methodological quality assessment to ensure the consistency of their conclusions (<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B31" ref-type="bibr">31</xref>).</p><p>Despite the essential role of the AMSTAR-2 tool in evaluating the methodological quality of systematic reviews, we recognize its limitations. The AMSTAR-2 scoring system emphasizes critical items, specifically questions 2, 4, 7, 9, 11, 13, and 15, where a single critical flaw can downgrade an otherwise "high-quality review to "low" or "critically low". This approach can result in assessments that do not accurately reflect the robustness of a review. For instance, reviews with multiple minor issues might receive a more favorable rating than those with a single critical error. Moreover, AMSTAR-2 tends to overemphasize the procedural components of conducting a review, potentially neglecting other crucial elements such as the clinical relevance of the research questions and the accurate interpretation of findings.</p><p>The tool also contains ambiguities in some of its critical questions, which may lead to assessment inconsistencies among different reviewers. is the question regarding the analysis of publication bias, which is deemed a critical failure if not conducted, even in scenarios where such analysis may not be applicable due to a limited number of studies (<xref rid="B32" ref-type="bibr">32</xref>). This strict adherence to criteria can unjustly penalize reviews that, for methodologically sound reasons, do not perform this analysis. Thus, it is essential for users of AMSTAR-2 to interpret the ratings with caution, acknowledging these limitations and opting for a more comprehensive evaluation of the methodological quality of systematic reviews. Recognizing these constraints is crucial for the effective use of the tool, ensuring that conclusions drawn from its application are both reliable and relevant for clinical practice and health policy development.</p><p>Systematic review results indicate that immediate post-surgery cryotherapy effectively reduces pain and swelling, supporting its recognized anti-inflammatory and analgesic effects. The pain reduction achieved through cryotherapy primarily results from the blockade of nerve impulse transmission when local temperatures drop below 14&#x000b0;C, leading to pain perception reduction (<xref rid="B17" ref-type="bibr">17</xref>). This effect is influenced by variables such as the size and shape of the ice pack, application duration and frequency, tissue thickness at the application site, and methodological differences across studies (<xref rid="B18" ref-type="bibr">18</xref>). Moreover, cooling contributes to reduced postoperative swelling through its vasoconstrictive effects, which decrease neutrophil activity and inflammatory cytokine release, thus mitigating fluid accumulation (<xref rid="B17" ref-type="bibr">17</xref>). However, the results of reducing trismus are inconsistent, suggesting a need for more standardized cryotherapy protocols and further research into its optimal application parameters.</p><p>Traditional suturing techniques following third molar extractions aim to promote primary wound closure and minimize risks of postoperative bleeding and infection (<xref rid="B33" ref-type="bibr">33</xref>). However, emerging evidence suggests that secondary wound closure, which involves leaving the wound partially open, may more effectively alleviate pain and swelling post-surgery. This method promotes the interaction between the alveolus and the oral cavity, facilitating better drainage of inflammation (<xref rid="B34" ref-type="bibr">34</xref>). In contrast, suturing can induce trauma, damage capillaries, and trigger pro-inflammatory cytokines release, increasing vascular permeability and consequently swelling (<xref rid="B35" ref-type="bibr">35</xref>). Despite these potential benefits, the data regarding secondary closure's effectiveness in reducing trismus, bleeding, and infection risks remain inconsistent and limited, underscoring the need for additional research to establish the efficacy of secondary closure across various clinical outcomes.</p><p>In recent years, chlorhexidine has become increasingly popular as an antiseptic in medicine and dentistry, favored for its antimicrobial efficacy, low cost, and ease of application (<xref rid="B36" ref-type="bibr">36</xref>). Particularly when used as a mouthwash, the best evidence indicates that chlorhexidine is effective in reducing postoperative alveolitis, while its application in gel form is considered probably beneficial in preventing this complication. The effectiveness of chlorhexidine is derived from its ability to disrupt biofilms and diminish oral pathogen loads (<xref rid="B37" ref-type="bibr">37</xref>), attribuTable to its broad-spectrum antimicrobial activity against both gram-positive and gram-negative bacteria. It functions as a bacteriostatic agent at lower doses and exhibits bactericidal properties at higher concentrations, with additional antifungal effects (<xref rid="B38" ref-type="bibr">38</xref>).</p><p>It is noteworthy that none of the systematic reviews included in this study assessed the impact of interventions on patients' quality of life, a key outcome for patient-centered evaluations. The omission of this critical dimension is concerning, as comprehending patients&#x02019; quality of life, satisfaction, and overall well-being is essential for informed decision-making and tailoring treatments to optimize patient experiences during third molar surgeries (<xref rid="B1" ref-type="bibr">1</xref>). This research gap significantly hinders our understanding and limits our ability to provide personalized care that aligns with individual patient needs. Prioritizing the inclusion of quality of life measures in future research should be a focus, ensuring these metrics are standard outcomes in clinical studies concerning third molar removals.</p><p>The primary limitation of this evidence mapping lies in its inability to analyze clinical and methodological heterogeneities among the trials included in the meta-analyses reviewed. These heterogeneities are critical for interpreting results, as they include differences in the characteristics of the third molars removed, variations in surgical procedures performed, the experience levels of the surgeons involved, and the use of medications in the pre- and post-operative phases. Such variations can significantly impact clinical outcomes and the efficacy of the interventions studied. The inability to detail and adjust for these clinical and methodological differences restricts the generalizability of the findings and may compromise the applicability of the clinical recommendations derived from this study. This issue underscores the need for more detailed and specific analyses that consider these critical variables in the planning of future research and in the formulation of evidence-based guidelines.</p></sec><sec><title>Conclusions</title><p>This evidence mapping revealed a predominantly low methodological quality among systematic reviews and meta-analyses that evaluated the effects of cryotherapy, surgical wound closure, and chlorhexidine following third molar surgery. Regarding the interventions:</p><p>1. Cryotherapy showed probable benefits in reducing pain and swelling on the second postoperative day. However, its effectiveness on other postoperative days and for reducing trismus remains unsupported by high-quality evidence. These findings suggest that while cryotherapy may be beneficial shortly after surgery, its broader applications require more robust investigation.</p><p>2. Secondary closure was generally found to be beneficial or probably beneficial in reducing pain, swelling, and trismus during the first week post-surgery. However, high-quality evidence supports its benefit only in reducing pain on the first postoperative day and swelling after seven days. There is no substantial evidence supporting its effectiveness in reducing bleeding, infection, or alveolitis risk, highlighting the need for more high-quality research in these areas.</p><p>3. Chlorhexidine, particularly as a mouthwash, was consistently beneficial in preventing postoperative alveolitis. This suggests that chlorhexidine remains a valuable antiseptic tool in managing complications following third molar extractions.</p><p>In conclusion, while some interventions show potential benefits, the overall low quality of the evidence necessitates cautious interpretation of these results. Future research should prioritize improving methodological standards and expanding investigations into the patient-centered outcomes and the longitudinal effects of these interventions to better guide clinical practice.</p></sec></body><back><ack><title>Acknowledgement</title><p>PRMF and FWGC are research productivity fellows at the National Council for Scientific and Technological Development (CNPq), Brazil.</p></ack><sec><title>Funding</title><p>This study did not receive financial support.</p></sec><sec sec-type="COI-statement"><title>Conflict of interest</title><p>The authors declare no conflict of interest, financial or otherwise.</p></sec><notes><title>Institutional Review Board Statement</title><p>Declared none.</p></notes><notes><title>Author Contributions</title><p>- Conception/design of the research: Edmundo Marques do Nascimento-J&#x000fa;nior, Paulo Ricardo Martins-Filho;
- Study selection: Edmundo Marques do Nascimento-J&#x000fa;nior, Paulo Ricardo Martins-Filho;
- Data collection: Edmundo Marques do Nascimento-J&#x000fa;nior, Paulo Ricardo Martins-Filho;
-Data analysis/interpretation: Edmundo Marques do Nascimento-J&#x000fa;nior, F&#x000e1;bio Wildson Gurgel Costa, Paulo Ricardo Martins-Filho;
- Supervision: Paulo Ricardo Martins-Filho, F&#x000e1;bio Wildson Gurgel Costa;
-Drafting the manuscript or making intellectual contributions on text/revisions: Edmundo Marques do Nascimento-J&#x000fa;nior, F&#x000e1;bio Wildson Gurgel Costa, Paulo Ricardo Martins-Filho;
-Final approval of the manuscript: Edmundo Marques do Nascimento-J&#x000fa;nior, F&#x000e1;bio Wildson Gurgel Costa, Paulo Ricardo Martins-Filho.</p></notes><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duarte-Rodrigues</surname><given-names>L</given-names></name><name><surname>Miranda</surname><given-names>EFP</given-names></name><name><surname>Souza</surname><given-names>TO</given-names></name><name><surname>de Paiva</surname><given-names>HN</given-names></name><name><surname>Falci</surname><given-names>SGM</given-names></name><name><surname>Galv&#x000e3;o</surname><given-names>EL</given-names></name></person-group><article-title>Third molar removal and its impact on quality of life: Systematic review and meta-analysis</article-title><source>Qual Life Res</source><year>2018</year><volume>27</volume><fpage>2477</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">29797177</pub-id>
</element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shugars</surname><given-names>DA</given-names></name><name><surname>Gentile</surname><given-names>MA</given-names></name><name><surname>Ahmad</surname><given-names>N</given-names></name><name><surname>Stavropoulos</surname><given-names>MF</given-names></name><name><surname>Slade</surname><given-names>GD</given-names></name><name><surname>Phillips</surname><given-names>C</given-names></name></person-group><article-title>Assessment of oral health-related quality of life before and after third molar surgery</article-title><source>J Oral Maxillofac Surg</source><year>2006</year><volume>64</volume><fpage>1721</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">17113437</pub-id>
</element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>H</given-names></name><name><surname>Lynham</surname><given-names>A</given-names></name><name><surname>Hsu</surname><given-names>E</given-names></name></person-group><article-title>Postoperative interventions to reduce inflammatory complications after third molar surgery: Review of the current evidence</article-title><source>Aust Dent J</source><year>2017</year><volume>62</volume><fpage>412</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">28498604</pub-id>
</element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malkawi</surname><given-names>Z</given-names></name><name><surname>Al-Omiri</surname><given-names>MK</given-names></name><name><surname>Khraisat</surname><given-names>A</given-names></name></person-group><article-title>Risk indicators of postoperative complications following surgical extraction of lower third molars</article-title><source>Med Princ Pract</source><year>2011</year><volume>20</volume><fpage>321</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">21576990</pub-id>
</element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGrath</surname><given-names>C</given-names></name><name><surname>Comfort</surname><given-names>MB</given-names></name><name><surname>Lo</surname><given-names>ECM</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name></person-group><article-title>Changes in life quality following third molar surgery--the immediate postoperative period</article-title><source>Br Dent J</source><year>2003</year><volume>194</volume><fpage>265</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12658303</pub-id>
</element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forouzanfar</surname><given-names>T</given-names></name><name><surname>Sabelis</surname><given-names>A</given-names></name><name><surname>Ausems</surname><given-names>S</given-names></name><name><surname>Baart</surname><given-names>JA</given-names></name><name><surname>Van-der-Waal</surname><given-names>I</given-names></name></person-group><article-title>Effect of ice compression on pain after mandibular third molar surgery: A single-blind, randomized controlled trial</article-title><source>Int J Oral Maxillofac Surg</source><year>2008</year><volume>37</volume><fpage>824</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">18603410</pub-id>
</element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bello</surname><given-names>SA</given-names></name><name><surname>Olaitan</surname><given-names>AA</given-names></name><name><surname>Ladeinde</surname><given-names>AL</given-names></name></person-group><article-title>A randomized comparison of the effect of partial and total wound closure techniques on postoperative morbidity after mandibular third molar surgery</article-title><source>J Oral Maxillofac Surg</source><year>2011</year><volume>69</volume><fpage>e24</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">21497001</pub-id>
</element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balamurugan</surname><given-names>R</given-names></name><name><surname>Zachariah</surname><given-names>T</given-names></name></person-group><article-title>Comparison of primary and secondary closure with a buccal mucosal-advancement flap on postoperative course after mandibular impacted third molar surgery</article-title><source>Oral Maxillofac Surg</source><year>2020</year><volume>24</volume><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">31729607</pub-id>
</element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halabi</surname><given-names>D</given-names></name><name><surname>Escobar</surname><given-names>J</given-names></name><name><surname>Alvarado</surname><given-names>C</given-names></name><name><surname>Martinez</surname><given-names>N</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>C</given-names></name></person-group><article-title>Chlorhexidine for prevention of alveolar osteitis: A randomised clinical trial</article-title><source>J Appl Oral Sci</source><year>2018</year><volume>26</volume><fpage>e20170245</fpage><pub-id pub-id-type="pmid">29742264</pub-id>
</element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres-Lagares</surname><given-names>D</given-names></name><name><surname>Gutierrez-Perez</surname><given-names>JL</given-names></name><name><surname>Infante-Cossio</surname><given-names>P</given-names></name><name><surname>Garcia-Calderon</surname><given-names>M</given-names></name><name><surname>Romero-Ruiz</surname><given-names>MM</given-names></name><name><surname>Serrera-Figallo</surname><given-names>MA</given-names></name></person-group><article-title>Randomized, double-blind study on effectiveness of intra-alveolar chlorhexidine gel in reducing the incidence of alveolar osteitis in mandibular third molar surgery</article-title><source>Int J Oral Maxillofac Surg</source><year>2006</year><volume>35</volume><fpage>348</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">16289676</pub-id>
</element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zandi</surname><given-names>M</given-names></name><name><surname>Amini</surname><given-names>P</given-names></name><name><surname>Keshavarz</surname><given-names>A</given-names></name></person-group><article-title>Effectiveness of cold therapy in reducing pain, trismus, and oedema after impacted mandibular third molar surgery: A randomized, self-controlled, observer-blind, split-mouth clinical trial</article-title><source>Int J Oral Maxillofac Surg</source><year>2016</year><volume>45</volume><fpage>118</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">26597577</pub-id>
</element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bragge</surname><given-names>P</given-names></name><name><surname>Clavisi</surname><given-names>O</given-names></name><name><surname>Turner</surname><given-names>T</given-names></name><name><surname>Tavender</surname><given-names>E</given-names></name><name><surname>Collie</surname><given-names>A</given-names></name><name><surname>Gruen</surname><given-names>RL</given-names></name></person-group><article-title>The global evidence mapping initiative: Scoping research in broad topic areas</article-title><source>BMC Med Res Methodol</source><year>2011</year><volume>11</volume><fpage>92</fpage><pub-id pub-id-type="pmid">21682870</pub-id>
</element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tricco</surname><given-names>AC</given-names></name><name><surname>Lillie</surname><given-names>E</given-names></name><name><surname>Zarin</surname><given-names>W</given-names></name><name><surname>O'brien</surname><given-names>KK</given-names></name><name><surname>Colquhoun</surname><given-names>H</given-names></name><name><surname>Levac</surname><given-names>D</given-names></name></person-group><article-title>PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation</article-title><source>Ann Intern Med</source><year>2018</year><volume>169</volume><fpage>467</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">30178033</pub-id>
</element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anaya</surname><given-names>MM</given-names></name><name><surname>Franco</surname><given-names>JVA</given-names></name><name><surname>Ballesteros</surname><given-names>M</given-names></name><name><surname>Sol&#x000e0;</surname><given-names>I</given-names></name><name><surname>Cuch&#x000ed;</surname><given-names>GU</given-names></name><name><surname>Cosp</surname><given-names>XB</given-names></name></person-group><article-title>Evidence mapping and quality assessment of systematic reviews on therapeutic interventions for oral cancer</article-title><source>Cancer Manag Res</source><year>2019</year><volume>11</volume><fpage>117</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">30636891</pub-id>
</element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shea</surname><given-names>BJ</given-names></name><name><surname>Reeves</surname><given-names>BC</given-names></name><name><surname>Wells</surname><given-names>G</given-names></name><name><surname>Thuku</surname><given-names>M</given-names></name><name><surname>Hamel</surname><given-names>C</given-names></name><name><surname>Moran</surname><given-names>J</given-names></name></person-group><article-title>AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both</article-title><source>BMJ</source><year>2017</year><volume>358</volume><fpage>j4008</fpage><pub-id pub-id-type="pmid">28935701</pub-id>
</element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyatt</surname><given-names>GH</given-names></name><name><surname>Oxman</surname><given-names>AD</given-names></name><name><surname>Kunz</surname><given-names>R</given-names></name><name><surname>Vist</surname><given-names>GE</given-names></name><name><surname>Falck-Ytter</surname><given-names>Y</given-names></name><name><surname>Sch&#x000fc;nemann</surname><given-names>HJ</given-names></name></person-group><article-title>What is "quality of evidence" and why is it important to clinicians?</article-title><source>BMJ</source><year>2008</year><volume>336</volume><fpage>995</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18456631</pub-id>
</element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>IA</given-names></name><name><surname>Armond</surname><given-names>ACV</given-names></name><name><surname>Falci</surname><given-names>SGM</given-names></name></person-group><article-title>The effectiveness of the cold therapy (cryotherapy) in the management of inflammatory parameters after removal of mandibular third molars: A meta-analysis</article-title><source>Int Arch Otorhinolaryngol</source><year>2019</year><volume>23</volume><fpage>221</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">30956709</pub-id>
</element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nascimento-J&#x000fa;nior</surname><given-names>EM</given-names></name><name><surname>Santos</surname><given-names>GMS</given-names></name><name><surname>Mendes</surname><given-names>MLT</given-names></name><name><surname>Cenci</surname><given-names>M</given-names></name><name><surname>Correa</surname><given-names>MB</given-names></name><name><surname>Cenci</surname><given-names>TP</given-names></name></person-group><article-title>Cryotherapy in reducing pain, trismus, and facial swelling after third-molar surgery: Systematic review and meta-analysis of randomized clinical trials</article-title><source>J Am Dent Assoc</source><year>2019</year><volume>150</volume><fpage>269</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">30798949</pub-id>
</element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azab</surname><given-names>M</given-names></name><name><surname>Ibrahim</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Carrasco-Labra</surname><given-names>A</given-names></name><name><surname>Zeng</surname><given-names>L</given-names></name><name><surname>Brignardello-Petersen</surname><given-names>R</given-names></name></person-group><article-title>Efficacy of secondary vs primary closure techniques for the prevention of postoperative complications after impacted mandibular third molar extractions: A systematic review update and meta-analysis</article-title><source>J Am Dent Assoc</source><year>2022</year><volume>153</volume><fpage>943</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">36030117</pub-id>
</element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>E</given-names></name><name><surname>Kashbour</surname><given-names>W</given-names></name><name><surname>Shah</surname><given-names>N</given-names></name><name><surname>Worthington</surname><given-names>HV</given-names></name><name><surname>Renton</surname><given-names>TF</given-names></name><name><surname>Coulthard</surname><given-names>P</given-names></name></person-group><article-title>Surgical techniques for the removal of mandibular wisdom teeth</article-title><source>Cochrane Database Syst Rev</source><year>2020</year><volume>7</volume><fpage>CD004345</fpage><pub-id pub-id-type="pmid">32712962</pub-id>
</element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrasco-Labra</surname><given-names>A</given-names></name><name><surname>Brignardello-Petersen</surname><given-names>R</given-names></name><name><surname>Yanine</surname><given-names>N</given-names></name><name><surname>Araya</surname><given-names>I</given-names></name><name><surname>Guyatt</surname><given-names>G</given-names></name></person-group><article-title>Secondary versus primary closure techniques for the prevention of postoperative complications following removal of impacted mandibular third molars: A systematic review and meta-analysis of randomized controlled trials</article-title><source>J Oral Maxillofac Surg</source><year>2012</year><volume>70</volume><fpage>e441</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">22695015</pub-id>
</element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name></person-group><article-title>Efficacy of secondary closure technique after extraction of third molars: A meta-analysis</article-title><source>Br J Oral Maxillofac Surg</source><year>2019</year><volume>57</volume><fpage>977</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">31540844</pub-id>
</element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falci</surname><given-names>SGM</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>MTB&#x000c1;</given-names></name><name><surname>Canarim</surname><given-names>NM</given-names></name><name><surname>Falci</surname><given-names>SE</given-names></name><name><surname>Martins</surname><given-names>OBL</given-names></name><name><surname>de Souza</surname><given-names>GM</given-names></name></person-group><article-title>Comparison of suture and sutureless techniques on postoperative complications after third molar surgery: a systematic review</article-title><source>Clin Oral Investig</source><year>2024</year><volume>28</volume><fpage>115</fpage><pub-id pub-id-type="pmid">38267703</pub-id>
</element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caso</surname><given-names>A</given-names></name><name><surname>Hung</surname><given-names>LK</given-names></name><name><surname>Beirne</surname><given-names>OR</given-names></name></person-group><article-title>Prevention of alveolar osteitis with chlorhexidine: A meta-analytic review</article-title><source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source><year>2005</year><volume>99</volume><fpage>155</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">15660084</pub-id>
</element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez S&#x000e1;nchez</surname><given-names>F</given-names></name><name><surname>Rodr&#x000ed;guez Andr&#x000e9;s</surname><given-names>C</given-names></name><name><surname>Arteagoitia Calvo</surname><given-names>I</given-names></name></person-group><article-title>Does chlorhexidine prevent alveolar osteitis after third molar extractions? Systematic review and meta-analysis</article-title><source>J Oral Maxillofac Surg</source><year>2017</year><volume>75</volume><fpage>901</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">28189661</pub-id>
</element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teshome</surname><given-names>A</given-names></name></person-group><article-title>The efficacy of chlorhexidine gel in the prevention of alveolar osteitis after mandibular third molar extraction: A systematic review and meta-analysis</article-title><source>BMC Oral Health</source><year>2017</year><volume>17</volume><fpage>82</fpage><pub-id pub-id-type="pmid">28526078</pub-id>
</element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Song</surname><given-names>J</given-names></name></person-group><article-title>The efficacy of intra-alveolar 0.2% chlorhexidine gel on alveolar osteitis: a meta-analysis</article-title><source>Oral Dis</source><year>2017</year><volume>23</volume><fpage>598</fpage><lpage>608</lpage><pub-id pub-id-type="pmid">27479137</pub-id>
</element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daly</surname><given-names>BJM</given-names></name><name><surname>Sharif</surname><given-names>MO</given-names></name><name><surname>Jones</surname><given-names>K</given-names></name><name><surname>Worthington H</surname><given-names>V</given-names></name></person-group><article-title>, Beattie A. Local interventions for the management of alveolar osteitis (dry socket)</article-title><source>Cochrane Database Syst Rev</source><year>2022</year><volume>9</volume><fpage>CD006968</fpage><pub-id pub-id-type="pmid">36156769</pub-id>
</element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero-Olid</surname><given-names>MN</given-names></name><name><surname>Bucataru</surname><given-names>E</given-names></name><name><surname>Ramos-Garc&#x000ed;a</surname><given-names>P</given-names></name><name><surname>Gonz&#x000e1;lez-Moles</surname><given-names>M&#x000c1;</given-names></name></person-group><article-title>Efficacy of Chlorhexidine after Oral Surgery Procedures on Wound Healing: Systematic Review and Meta-Analysis</article-title><source>Antibiotics (Basel)</source><year>2023</year><volume>12</volume><pub-id pub-id-type="pmid">37887254</pub-id>
</element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>GF</given-names></name><name><surname>Audrey</surname><given-names>S</given-names></name><name><surname>Barker</surname><given-names>M</given-names></name><name><surname>Bond</surname><given-names>L</given-names></name><name><surname>Bonell</surname><given-names>C</given-names></name><name><surname>Hardeman</surname><given-names>W</given-names></name></person-group><article-title>Process evaluation of complex interventions: Medical Research Council guidance</article-title><source>BMJ</source><year>2015</year><volume>350</volume><pub-id pub-id-type="pmid">25791983</pub-id>
</element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballesteros</surname><given-names>M</given-names></name><name><surname>Montero</surname><given-names>N</given-names></name><name><surname>L&#x000f3;pez-Pousa</surname><given-names>A</given-names></name><name><surname>Urr&#x000fa;tia</surname><given-names>G</given-names></name><name><surname>Sol&#x000e0;</surname><given-names>I</given-names></name><name><surname>Rada</surname><given-names>G</given-names></name></person-group><article-title>Evidence mapping based on systematic reviews of therapeutic interventions for gastrointestinal stromal tumors (GIST)</article-title><source>BMC Med Res Methodol</source><year>2017</year><volume>17</volume><fpage>135</fpage><pub-id pub-id-type="pmid">28882125</pub-id>
</element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simmonds</surname><given-names>M</given-names></name></person-group><article-title>Quantifying the risk of error when interpreting funnel plots</article-title><source>Syst Rev</source><year>2015</year><volume>4</volume><fpage>24</fpage><pub-id pub-id-type="pmid">25875027</pub-id>
</element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyall</surname><given-names>JB</given-names></name></person-group><article-title>Third Molar Surgery: The Effect of Primary Closure, Wound Dressing and Metronidazole on Postoperative Recovery</article-title><source>J R Army Med Corps</source><year>1991</year><volume>137</volume><fpage>100</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">1875313</pub-id>
</element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menziletoglu</surname><given-names>D</given-names></name><name><surname>Guler</surname><given-names>AY</given-names></name><name><surname>Basturk</surname><given-names>F</given-names></name><name><surname>Isik</surname><given-names>BK</given-names></name></person-group><article-title>Comparison of Surgical Drain Placement with Use of Kinesiologic Tape on Postoperative Pain, Swelling, and Trismus in Impacted Mandibular Third Molar Surgery</article-title><source>J Oral Maxillofac Surg</source><year>2020</year><volume>78</volume><fpage>1919.e1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">32673573</pub-id>
</element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pachipulusu</surname><given-names>PK</given-names></name><name><surname>S</surname><given-names>M</given-names></name></person-group><article-title>Comparative study of primary and secondary closure of the surgical wound after removal of impacted mandibular third molars</article-title><source>Oral Maxillofac Surg</source><year>2018</year><volume>22</volume><fpage>261</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">29796741</pub-id>
</element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiorillo</surname><given-names>L</given-names></name></person-group><article-title>Chlorhexidine Gel Use in the Oral District: A Systematic Review</article-title><source>Gels</source><year>2019</year><volume>5</volume><fpage>31</fpage><pub-id pub-id-type="pmid">31212600</pub-id>
</element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanz</surname><given-names>M</given-names></name><name><surname>Newman</surname><given-names>MG</given-names></name><name><surname>Anderson</surname><given-names>L</given-names></name><name><surname>Matoska</surname><given-names>W</given-names></name><name><surname>Otomo-Corgel</surname><given-names>J</given-names></name><name><surname>Saltini</surname><given-names>C</given-names></name></person-group><article-title>Clinical Enhancement of Post&#x02010;Periodontal Surgical Therapy by a 0.12% Chlorhexidine Gluconate Mouthrinse</article-title><source>J Periodontol</source><year>1989</year><volume>60</volume><fpage>570</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">2681675</pub-id>
</element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hugo</surname><given-names>WB</given-names></name><name><surname>Longworth</surname><given-names>AR</given-names></name></person-group><article-title>The effect of chlorhexidine on the electrophoretic mobility, cytoplasmic constituents, dehydrogenase activity and cell walls of Escherichia coli and Staphylococcus aureus</article-title><source>J Pharm Pharmacol</source><year>2011</year><volume>18</volume><fpage>569</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">4381940</pub-id>
</element-citation></ref></ref-list></back><floats-group><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Characteristics of the meta-analyses included in the evidence mapping. </p></caption><table frame="border" rules="all" width="100%"><thead><tr><th rowspan="2" colspan="1">
</th><th rowspan="2" colspan="1">Author
(year)</th><th rowspan="2" colspan="1">Trials</th><th colspan="2" rowspan="1">Intervention vs. Control</th><th rowspan="2" colspan="1">Outcomes of interest</th></tr><tr><th rowspan="1" colspan="1">Comparison</th><th rowspan="1" colspan="1">Time</th></tr></thead><tbody><tr><td rowspan="2" align="center" valign="middle" colspan="1">Cryotherapy</td><td align="center" valign="middle" rowspan="1" colspan="1">Fernandes
(2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">Ice pack vs.
no use of ice</td><td align="center" valign="middle" rowspan="1" colspan="1">Immediately and for 24h post-surgery</td><td align="center" valign="middle" rowspan="1" colspan="1">Edema and trismus</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nascimento-J&#x000fa;nior
(2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">Ice pack vs.
no use of ice</td><td align="center" valign="middle" rowspan="1" colspan="1">Immediately and for 24h post-surgery</td><td align="center" valign="middle" rowspan="1" colspan="1">Pain, edema, and trismus</td></tr><tr><td rowspan="5" align="center" valign="middle" colspan="1">Wound closure</td><td align="center" valign="middle" rowspan="1" colspan="1">Carrasco-Labra
(2012)</td><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">Secondary vs.
primary closure</td><td align="center" valign="middle" rowspan="1" colspan="1">Immediately after surgery</td><td align="center" valign="middle" rowspan="1" colspan="1">Pain, edema, trismus, bleeding, wound infection, and alveolitis</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ma
(2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">Secondary vs.
primary closure</td><td align="center" valign="middle" rowspan="1" colspan="1">Immediately after surgery</td><td align="center" valign="middle" rowspan="1" colspan="1">Pain, edema, and trismus</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Bailey
(2020)</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">Secondary vs.
primary closure</td><td align="center" valign="middle" rowspan="1" colspan="1">Immediately after surgery</td><td align="center" valign="middle" rowspan="1" colspan="1">Pain, edema, trismus, bleeding, wound infection, and alveolitis</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Azab
(2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">Secondary vs.
primary closure</td><td align="center" valign="middle" rowspan="1" colspan="1">Immediately after surgery</td><td align="center" valign="middle" rowspan="1" colspan="1">Pain, edema, trismus, bleeding, wound infection, and alveolitis</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Falci
(2024)</td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">Secondary vs.
primary closure</td><td align="center" valign="middle" rowspan="1" colspan="1">Immediately after surgery</td><td align="center" valign="middle" rowspan="1" colspan="1">Pain, edema, trismus, and bleeding</td></tr><tr><td rowspan="6" align="center" valign="middle" colspan="1">Chlorhexidine</td><td align="center" valign="middle" rowspan="1" colspan="1">Caso
(2005)</td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">CHX rinse vs.
placebo or others*</td><td align="center" valign="middle" rowspan="1" colspan="1">Pre- and post-surgery</td><td align="center" valign="middle" rowspan="1" colspan="1">Alveolitis</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rodr&#x000ed;guez-S&#x000e1;nchez
(2017)</td><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">CHX rinse and gel vs. placebo or others*</td><td align="center" valign="middle" rowspan="1" colspan="1">Rinse: pre- and post-surgery. Gel: intra-socket</td><td align="center" valign="middle" rowspan="1" colspan="1">Alveolitis</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Zhou
(2017)</td><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">CHX gel vs.
placebo or others*</td><td align="center" valign="middle" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" rowspan="1" colspan="1">Alveolitis</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Teshome
(2017)</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">CHX gel vs.
placebo or others*</td><td align="center" valign="middle" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" rowspan="1" colspan="1">Alveolitis</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Daly
(2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">CHX rinse and gel vs. placebo or others*</td><td align="center" valign="middle" rowspan="1" colspan="1">Rinse: before and 24h post-surgery. Gel: intra-socket</td><td align="center" valign="middle" rowspan="1" colspan="1">Alveolitis</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Romero-Olid
(2023)</td><td align="center" valign="middle" rowspan="1" colspan="1">33</td><td align="center" valign="middle" rowspan="1" colspan="1">CHX rinse and gel vs. placebo or others*</td><td align="center" valign="middle" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" rowspan="1" colspan="1">Alveolitis</td></tr></tbody></table><table-wrap-foot><fn><p>CHX, chlorhexidine. *Others: Saline solution, dressings, or no treatment.
</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Synthesis of extracted data on cryotherapy for reduction of pain, edema, and trismus after third molar extraction.</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th rowspan="1" colspan="1">
</th><th rowspan="1" colspan="1">Author (year)</th><th rowspan="1" colspan="1">Sample Size</th><th rowspan="1" colspan="1">Follow-up</th><th rowspan="1" colspan="1">Measurement</th><th rowspan="1" colspan="1">Effect</th></tr></thead><tbody><tr><td rowspan="4" align="center" valign="middle" colspan="1">Pain</td><td align="center" valign="middle" rowspan="1" colspan="1">Nascimento-Junior (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">124</td><td align="center" valign="middle" rowspan="1" colspan="1">POD1</td><td align="center" valign="middle" rowspan="1" colspan="1">MD 0.17 (-0.67 to 1.01)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nascimento-Junior (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">124</td><td align="center" valign="middle" rowspan="1" colspan="1">POD2</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -0.72 (-1.45 to -0.01)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nascimento-Junior (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">POD3</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -0.36 (-0.59 to -0.13)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nascimento-Junior (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">160</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -0.46 (-1.28 to 0.37)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td rowspan="5" align="center" valign="middle" colspan="1">Edema</td><td align="center" valign="middle" rowspan="1" colspan="1">Nascimento-Junior (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">88</td><td align="center" valign="middle" rowspan="1" colspan="1">POD2</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -0.28 (-0.88 to 0.31)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nascimento-Junior (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">36</td><td align="center" valign="middle" rowspan="1" colspan="1">POD3</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -2.26 (-3.12 to -1.40)</td><td align="center" valign="middle" rowspan="1" colspan="1">Inconclusive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nascimento-Junior (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">96</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -0.52 (-1.92 to 0.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">Inconclusive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fernandes (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">85</td><td align="center" valign="middle" rowspan="1" colspan="1">POD2</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -0.94 (-1.49 to -0.39)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fernandes (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">85</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -0.35 (-1.34 to 0.64)</td><td align="center" valign="middle" rowspan="1" colspan="1">Inconclusive</td></tr><tr><td rowspan="7" align="center" valign="middle" colspan="1">Trismus</td><td align="center" valign="middle" rowspan="1" colspan="1">Nascimento-Junior (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">118</td><td align="center" valign="middle" rowspan="1" colspan="1">POD1</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -0.27 (-3.81 to 3.26)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nascimento-Junior (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">88</td><td align="center" valign="middle" rowspan="1" colspan="1">POD2</td><td align="center" valign="middle" rowspan="1" colspan="1">MD 0.22 (-3.49 to 3.93)</td><td align="center" valign="middle" rowspan="1" colspan="1">Inconclusive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nascimento-Junior (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">36</td><td align="center" valign="middle" rowspan="1" colspan="1">POD3</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -0.63 (-1.60 to 0.34)</td><td align="center" valign="middle" rowspan="1" colspan="1">Inconclusive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nascimento-Junior (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">186</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -0.04 (-0.63 to 0.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">Inconclusive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fernandes (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">143</td><td align="center" valign="middle" rowspan="1" colspan="1">POD1</td><td align="center" valign="middle" rowspan="1" colspan="1">MD 0.55 (-2.14 to 3.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">Inconclusive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fernandes (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">85</td><td align="center" valign="middle" rowspan="1" colspan="1">POD2</td><td align="center" valign="middle" rowspan="1" colspan="1">MD 2.37 (-0.50 to 5.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fernandes (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">203</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">MD 0.76 (-3.10 to 4.63)</td><td align="center" valign="middle" rowspan="1" colspan="1">Inconclusive</td></tr></tbody></table><table-wrap-foot><fn><p>POD1, first postoperative day; POD2, second postoperative day; POD3, third postoperative day; POD7, seventh postoperative day; MD, mean difference; SMD, standardized mean difference.</p><p>Negative effect measures for continuous outcomes indicated favorability towards cryotherapy.
</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Synthesis of extracted data on secondary versus primary closure for reduction of pain, edema, and trismus, and prevention of bleeding, surgical wound infection, and alveolitis after third molar removal.</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th rowspan="1" colspan="1">
</th><th rowspan="1" colspan="1">Author (year)</th><th rowspan="1" colspan="1">Sample Size</th><th rowspan="1" colspan="1">Follow-up</th><th rowspan="1" colspan="1">Measurement</th><th rowspan="1" colspan="1">Effect</th></tr></thead><tbody><tr><td rowspan="12" colspan="1">Pain</td><td align="center" valign="middle" rowspan="1" colspan="1">Carrasco-Labra (2012)</td><td align="center" valign="middle" rowspan="1" colspan="1">570</td><td align="center" valign="middle" rowspan="1" colspan="1">POD3</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -0.29 (-0.63 to 0.05)</td><td align="center" valign="middle" rowspan="1" colspan="1">Inconclusive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Carrasco-Labra (2012)</td><td align="center" valign="middle" rowspan="1" colspan="1">364</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD 0.00 (-0.19 to 0.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">Inconclusive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ma (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">332</td><td align="center" valign="middle" rowspan="1" colspan="1">POD2-3</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -0.49 (-0.71 to -0.27)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ma (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">332</td><td align="center" valign="middle" rowspan="1" colspan="1">POD5-7</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -1.12 (-1.57 to -0.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">Beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Bailey (2020)</td><td align="center" valign="middle" rowspan="1" colspan="1">474</td><td align="center" valign="middle" rowspan="1" colspan="1">POD1</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -0.94 (-1.38 to -0.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">Beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Azab (2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">2114</td><td align="center" valign="middle" rowspan="1" colspan="1">POD1</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -1.12 (-1.46 to -0.78)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Azab (2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">2338</td><td align="center" valign="middle" rowspan="1" colspan="1">POD3</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -0.97 (-1.26 to -0.69)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Azab (2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">2572</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -0.30 (-0.41 to -0.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Falci (2024)</td><td align="center" valign="middle" rowspan="1" colspan="1">200</td><td align="center" valign="middle" rowspan="1" colspan="1">POD1</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -1.08 (-1.35 to -0.81)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Falci (2024)</td><td align="center" valign="middle" rowspan="1" colspan="1">200</td><td align="center" valign="middle" rowspan="1" colspan="1">POD2</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -0.50 (-0.83 to -0.17)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Falci (2024)</td><td align="center" valign="middle" rowspan="1" colspan="1">167</td><td align="center" valign="middle" rowspan="1" colspan="1">POD3</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -0.05 (-0.75 to 0.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Falci (2024)</td><td align="center" valign="middle" rowspan="1" colspan="1">130</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">MD 0.00 (-0.03 to 0.03)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td rowspan="12" colspan="1">Edema</td><td align="center" valign="middle" rowspan="1" colspan="1">Carrasco-Labra (2012)</td><td align="center" valign="middle" rowspan="1" colspan="1">342</td><td align="center" valign="middle" rowspan="1" colspan="1">POD3</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -0.37 (-0.76 to 0.02)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Carrasco-Labra (2012)</td><td align="center" valign="middle" rowspan="1" colspan="1">324</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -0.15 (-0.39 to 0.10)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ma (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">518</td><td align="center" valign="middle" rowspan="1" colspan="1">POD2-3</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -0.36 (-0.54 to -0.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">Beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ma (2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">518</td><td align="center" valign="middle" rowspan="1" colspan="1">POD5-7</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -0.51 (-0.68 to -0.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">Beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Bailey (2020)</td><td align="center" valign="middle" rowspan="1" colspan="1">557</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -0.33 (-0.57 to -0.09)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Azab (2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">694</td><td align="center" valign="middle" rowspan="1" colspan="1">POD1</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -1.07 (-1.49 to -0.65)</td><td align="center" valign="middle" rowspan="1" colspan="1">Beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Azab (2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">636</td><td align="center" valign="middle" rowspan="1" colspan="1">POD3</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -1.14 (-1.75 to -0.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">Beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Azab (2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">726</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -1.11 (-1.77 to -0.45)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Falci (2024)</td><td align="center" valign="middle" rowspan="1" colspan="1">200</td><td align="center" valign="middle" rowspan="1" colspan="1">POD1</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -1.23 (-2.34 to -0.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Falci (2024)</td><td align="center" valign="middle" rowspan="1" colspan="1">200</td><td align="center" valign="middle" rowspan="1" colspan="1">POD2</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -0.66 (-1.16 to -0.16)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Falci (2024)</td><td align="center" valign="middle" rowspan="1" colspan="1">70</td><td align="center" valign="middle" rowspan="1" colspan="1">POD3</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -0.14 (-0.61 to 0.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">Inconclusive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Falci (2024)</td><td align="center" valign="middle" rowspan="1" colspan="1">80</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD 0.00 (-0.44 to 0.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">Inconclusive</td></tr><tr><td rowspan="9" colspan="1">Trismus</td><td align="center" valign="middle" rowspan="1" colspan="1">Carrasco-Labra (2012)</td><td align="center" valign="middle" rowspan="1" colspan="1">428</td><td align="center" valign="middle" rowspan="1" colspan="1">POD3</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -3.72 (-6.03 to -1.42)</td><td align="center" valign="middle" rowspan="1" colspan="1">Beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Carrasco-Labra (2012)</td><td align="center" valign="middle" rowspan="1" colspan="1">328</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -2.35 (-4.33 to -0.37)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Bailey (2020)</td><td align="center" valign="middle" rowspan="1" colspan="1">274</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">MD 0.29 (-0.32 to 0.90)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Azab (2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">1552</td><td align="center" valign="middle" rowspan="1" colspan="1">POD1</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -4.25 (-5.70 to -2.79)</td><td align="center" valign="middle" rowspan="1" colspan="1">Beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Azab (2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">1540</td><td align="center" valign="middle" rowspan="1" colspan="1">POD3</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -4.14 (-5.84 to -2.45)</td><td align="center" valign="middle" rowspan="1" colspan="1">Beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Azab (2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">1782</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">MD -2.58 (-3.75 to -1.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Falci (2024)</td><td align="center" valign="middle" rowspan="1" colspan="1">130</td><td align="center" valign="middle" rowspan="1" colspan="1">POD1</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -1.04 (-1.41 to -0.67)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Falci (2024)</td><td align="center" valign="middle" rowspan="1" colspan="1">130</td><td align="center" valign="middle" rowspan="1" colspan="1">POD2</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -1.54 (-3.31 to 0.23)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Falci (2024)</td><td align="center" valign="middle" rowspan="1" colspan="1">130</td><td align="center" valign="middle" rowspan="1" colspan="1">POD7</td><td align="center" valign="middle" rowspan="1" colspan="1">SMD -1.26 (-3.14 to 0.62)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td rowspan="2" align="center" valign="middle" colspan="1">Bleeding</td><td align="center" valign="middle" rowspan="1" colspan="1">Bailey (2020)</td><td align="center" valign="middle" rowspan="1" colspan="1">82</td><td align="center" valign="middle" rowspan="1" colspan="1">30 days</td><td align="center" valign="middle" rowspan="1" colspan="1">RR 2.45 (0.68 to 8.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">Inconclusive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Azab (2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">696</td><td align="center" valign="middle" rowspan="1" colspan="1">2-31 days</td><td align="center" valign="middle" rowspan="1" colspan="1">RD 0.00 (-0.04 to 0.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td rowspan="3" align="center" valign="middle" colspan="1">Wound infection</td><td align="center" valign="middle" rowspan="1" colspan="1">Carrasco-Labra (2012)</td><td align="center" valign="middle" rowspan="1" colspan="1">620</td><td align="center" valign="middle" rowspan="1" colspan="1">1 week</td><td align="center" valign="middle" rowspan="1" colspan="1">RR 0.51 (0.18 to 1.47)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Bailey (2020)</td><td align="center" valign="middle" rowspan="1" colspan="1">82</td><td align="center" valign="middle" rowspan="1" colspan="1">1 week</td><td align="center" valign="middle" rowspan="1" colspan="1">RR 0.21 (0.01 to 4.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">Inconclusive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Azab (2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">1002</td><td align="center" valign="middle" rowspan="1" colspan="1">2-31 days</td><td align="center" valign="middle" rowspan="1" colspan="1">RD 0.01 (-0.02 to 0.03)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td rowspan="3" align="center" valign="middle" colspan="1">Alveolitis</td><td align="center" valign="middle" rowspan="1" colspan="1">Carrasco-Labra (2012)</td><td align="center" valign="middle" rowspan="1" colspan="1">620</td><td align="center" valign="middle" rowspan="1" colspan="1">1 week</td><td align="center" valign="middle" rowspan="1" colspan="1">RR 0.51 (0.18 to 1.47)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Bailey (2020)</td><td align="center" valign="middle" rowspan="1" colspan="1">375</td><td align="center" valign="middle" rowspan="1" colspan="1">1 week</td><td align="center" valign="middle" rowspan="1" colspan="1">RR 1.01 (0.42 to 2.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Azab (2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">1598</td><td align="center" valign="middle" rowspan="1" colspan="1">20-31 days</td><td align="center" valign="middle" rowspan="1" colspan="1">RD 0.01 (-0.02 to 0.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">No effect</td></tr></tbody></table><table-wrap-foot><fn><p>POD1, first postoperative day; POD2, second postoperative day; POD3, third postoperative day; POD7, seventh postoperative day; POD2-3, between the second and third postoperative days; POD5-7, between the fifth and seventh postoperative days; MD, mean difference; SMD, standardized mean difference; RR, relative risk; RD, risk difference.</p><p>Negative effect measures for continuous outcomes indicated favorability towards secondary closure.
</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Synthesis of extracted data on chlorhexidine for prevention of alveolitis after third molar extraction.</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th rowspan="1" colspan="1">
</th><th rowspan="1" colspan="1">Author (year)</th><th rowspan="1" colspan="1">Formulations</th><th rowspan="1" colspan="1">Sample Size</th><th rowspan="1" colspan="1">Measurement</th><th rowspan="1" colspan="1">Effect</th></tr></thead><tbody><tr><td rowspan="9" colspan="1">Alveolite</td><td align="center" valign="middle" rowspan="1" colspan="1">Caso (2005)</td><td align="center" valign="middle" rowspan="1" colspan="1">Rinse vs. Control</td><td align="center" valign="middle" rowspan="1" colspan="1">825</td><td align="center" valign="middle" rowspan="1" colspan="1">RR 0.53 (0.41 to 0.69)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rodr&#x000ed;guez-S&#x000e1;nchez (2017)</td><td align="center" valign="middle" rowspan="1" colspan="1">Rinse vs. Control</td><td align="center" valign="middle" rowspan="1" colspan="1">1096</td><td align="center" valign="middle" rowspan="1" colspan="1">RR 0.58 (0.47 to 0.71)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rodr&#x000ed;guez-S&#x000e1;nchez (2017)</td><td align="center" valign="middle" rowspan="1" colspan="1">Gel vs. Control</td><td align="center" valign="middle" rowspan="1" colspan="1">1074</td><td align="center" valign="middle" rowspan="1" colspan="1">RR 0.47 (0.37 to 0.60)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Teshome (2017)</td><td align="center" valign="middle" rowspan="1" colspan="1">Gel vs. Control</td><td align="center" valign="middle" rowspan="1" colspan="1">968</td><td align="center" valign="middle" rowspan="1" colspan="1">RR 0.43 (0.32 to 0.58)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Zhou (2017)</td><td align="center" valign="middle" rowspan="1" colspan="1">Gel vs. Control</td><td align="center" valign="middle" rowspan="1" colspan="1">1043</td><td align="center" valign="middle" rowspan="1" colspan="1">OR 0.40 (0.28 to 0.55)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Daly (2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">Rinse vs. Control</td><td align="center" valign="middle" rowspan="1" colspan="1">1600</td><td align="center" valign="middle" rowspan="1" colspan="1">OR 0.38 (0.25 to 0.58)</td><td align="center" valign="middle" rowspan="1" colspan="1">Beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Daly (2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">Gel vs. Control</td><td align="center" valign="middle" rowspan="1" colspan="1">833</td><td align="center" valign="middle" rowspan="1" colspan="1">OR 0.44 (0.27 to 0.71)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Romero-Olid (2023)</td><td align="center" valign="middle" rowspan="1" colspan="1">Gel vs. Control</td><td align="center" valign="middle" rowspan="1" colspan="1">1523</td><td align="center" valign="middle" rowspan="1" colspan="1">RR 0.40 (0.31 to 0.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Romero-Olid (2023)</td><td align="center" valign="middle" rowspan="1" colspan="1">Rinse vs. Control</td><td align="center" valign="middle" rowspan="1" colspan="1">2679</td><td align="center" valign="middle" rowspan="1" colspan="1">RR 0.50 (0.41 to 0.62)</td><td align="center" valign="middle" rowspan="1" colspan="1">Probably beneficial</td></tr></tbody></table><table-wrap-foot><fn><p>RR, relative risk; OR, <italic>odds ratio</italic>.
</p></fn></table-wrap-foot></table-wrap></floats-group></article>